Latest Financials News

The Federal Court has imposed a $1.55 million penalty on Money3 Loans, a Solvar subsidiary, for limited breaches of the National Consumer Credit Act between 2019 and 2021. Solvar highlights strengthened governance and underwriting since the period in question.

Anagenics Limited delivered a third quarter operational performance aligned with budget following its restructuring, with cash outflows narrowing and its Bouf Haircare brand generating robust royalty revenue.

Kuniko Limited has launched a prospectus offering over 51 million new options following a $3.75 million share placement, aiming to facilitate secondary trading and potential future capital raising through option exercises.

Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.

Flynn Gold has reported standout assay results from its Tasmanian projects, including exceptional silver-lead-zinc grades at Silver King and significant tungsten-gold mineralisation at Firetower and Warrentinna, underpinning a ramp-up in drilling and regional exploration.

Atomos has finalized its acquisition of Flanders Scientific for $2.35 million cash plus shares, funded by a new $10 million finance facility from Commonwealth Bank. The deal broadens Atomos’ professional video monitoring reach and is expected to add $1 million EBITDA before growth.

Viking Mines has advanced its Linka Tungsten Project by completing a conceptual process flowsheet that incorporates recent metallurgical results and enables future processing upgrades. Preliminary engineering and cost evaluations are underway ahead of planned drilling in the June quarter.

Babylon Pump & Power’s shares remain suspended from ASX trading as the company delays disclosure of a material transaction and capital raising, prolonging market uncertainty beyond the initial deadline.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

Nido Education has expanded its footprint with a $9.1 million acquisition of four child care services, adding 348 places and an estimated $1.9 million annualised EBITDA. The company is also actively pursuing further acquisitions beyond its incubation pipeline amid sector demand challenges.

Marvel Gold has completed an extensive drone magnetic survey at its Hanang Gold Project in Tanzania, revealing new mineralisation corridors and preparing to launch its first drilling campaign. Meanwhile, the company is exiting Mali due to regulatory hurdles, progressing the sale of its Yanfolila project.

Albright Metals delivers strong high-grade gold results from its Golden Pike Project in Canada while boosting its balance sheet through a $1.8 million tenement sale to Catalyst Metals, sharpening its focus on high-impact assets.